Mettler-Toledo International, Inc. (NYSE:MTD)‘s stock had its “equal weight” rating reissued by equities researchers at Morgan Stanley in a report issued on Saturday. They currently have a $565.00 price objective on the medical instruments supplier’s stock, up from their previous price objective of $533.00. Morgan Stanley’s price target suggests a potential downside of 7.90% from the company’s current price.

A number of other research firms have also commented on MTD. Zacks Investment Research raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $538.00 price objective for the company in a research note on Wednesday, April 12th. Jefferies Group LLC reiterated a “hold” rating and issued a $550.00 target price on shares of Mettler-Toledo International in a report on Tuesday, June 20th. Bank of America Corporation upped their target price on Mettler-Toledo International from $590.00 to $630.00 and gave the company a “buy” rating in a report on Wednesday, May 31st. Cleveland Research upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating in a report on Wednesday, April 19th. Finally, BidaskClub upgraded Mettler-Toledo International from a “buy” rating to a “strong-buy” rating in a report on Wednesday, July 12th. Five analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $523.43.

Shares of Mettler-Toledo International (MTD) opened at 613.49 on Friday. The firm has a market cap of $15.84 billion, a PE ratio of 40.03 and a beta of 1.14. Mettler-Toledo International has a 52 week low of $380.35 and a 52 week high of $616.40. The company has a 50 day moving average of $594.37 and a 200 day moving average of $511.84.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, May 4th. The medical instruments supplier reported $3.34 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.08 by $0.26. The firm had revenue of $594.57 million during the quarter, compared to analyst estimates of $571.30 million. Mettler-Toledo International had a net margin of 16.04% and a return on equity of 90.28%. Mettler-Toledo International’s revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.46 EPS. On average, equities research analysts anticipate that Mettler-Toledo International will post $17.24 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/07/22/mettler-toledo-internationals-mtd-equal-weight-rating-reiterated-at-morgan-stanley.html.

In other news, CFO Shawn Vadala sold 700 shares of the stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $543.64, for a total value of $380,548.00. Following the completion of the sale, the chief financial officer now directly owns 6,225 shares of the company’s stock, valued at $3,384,159. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Francis A. Contino sold 725 shares of the stock in a transaction that occurred on Monday, May 8th. The shares were sold at an average price of $546.00, for a total value of $395,850.00. Following the completion of the sale, the director now directly owns 2,234 shares of the company’s stock, valued at $1,219,764. The disclosure for this sale can be found here. In the last quarter, insiders have sold 52,046 shares of company stock worth $28,826,702. Corporate insiders own 5.20% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Murphy Capital Management Inc. acquired a new stake in Mettler-Toledo International during the second quarter valued at $235,000. Bedrijfstakpensioenfonds Voor DE Media PNO acquired a new stake in Mettler-Toledo International during the second quarter valued at $1,524,000. Aperio Group LLC boosted its stake in Mettler-Toledo International by 20.7% in the second quarter. Aperio Group LLC now owns 17,643 shares of the medical instruments supplier’s stock valued at $10,384,000 after buying an additional 3,028 shares in the last quarter. Visionary Asset Management Inc. acquired a new stake in Mettler-Toledo International during the second quarter valued at $393,000. Finally, Nisa Investment Advisors LLC boosted its stake in Mettler-Toledo International by 10.3% in the second quarter. Nisa Investment Advisors LLC now owns 16,567 shares of the medical instruments supplier’s stock valued at $9,739,000 after buying an additional 1,547 shares in the last quarter. 95.31% of the stock is owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.